|
Press Releases
June 3, 2008
Provectus Pharmaceuticals Appoints Kelly M. McMasters, MD, PhD, to Board of Directors
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT
http://www.pvct.com)
has announced that Kelly M. McMasters MD, PhD, a preeminent authority on melanoma, has agreed to serve as a member of the corporate Board of Directors. Additionally, Dr. McMasters will head the scientific advisory board.
Read the complete article here.
May 28, 2008
Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Atopic Dermatitis
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT
http://www.pvct.com)
has begun Phase 2 clinical testing of PH-10, the company's topical drug for dermatology, for the treatment of atopic dermatitis, a chronic skin condition that includes some forms of eczema.
Read the complete article here.
May 22, 2008
Provectus Pharmaceuticals to Present at the 34th Annual Scientific Conference of the American Society of Photobiology
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT
http://www.pvct.com),
has announced that Provectus Chairman and CEO, Craig Dees, Ph.D. will present at the 34th Annual Scientific Conference of the American Society of Photobiology Monday, June 23, 9:00 am PDT to be held at the Burlingame Hilton California.
Read the complete article here.
April 29, 2008
Provectus Pharmaceuticals to Present at the Big Dog IV Small Cap Conference
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT,
http://www.pvct.com),
has announced that Provectus Chairman and CEO, Craig Dees, Ph.D. will present at the Big Dog IV Small Cap Conference being held at the Wynn Las Vegas on Friday, May 2nd, 2008 at 10:40 a.m. PDT.
Read the complete article here.
April 23, 2008
Provectus Pharmaceuticals Will Present at Inaugural LD MICRO Conference
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT,
http://www.pvct.com),
a development-stage oncology and dermatology biopharmaceutical company, has announced that it will present at LD MICRO's first annual conference at the Omni Los Angeles Hotel at 10:30 AM on April 29, 2008.
Read the complete article here.
April 15, 2008
Provectus Pharmaceuticals Receives Patent Allowance in the EU for PH-10 Dermatology Agent
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:
PVCT,
http://www.pvct.com),
a development-stage oncology and dermatology biopharmaceutical company, has received allowance of its patent application in the European Union covering its lead dermatology agent, PH-10, along with a number of related agents and their use. Provectus has also received allowance of another patent application in Canada covering applicator devices used with PH-10 and related agents. The pending patents cover topical products for treatment of skin diseases such as psoriasis and eczema, along with certain medical devices for application of PH-10 to internal surfaces of the body.
Read the complete article here.
|
